The US Meals and Drug Administration has authorised semaglutide 2.4 mg (Wegovy), a once-weekly subcutaneous injection, for the extra indication...
Teens
The Meals and Drug Administration’s approval of Wegovy, Novo Nordisk’s newest weight problems drug, for adolescents aged 12 years and...
.png)
